Results 91 to 100 of about 32,738 (290)

Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer

JAMA Network Open, 2020
Key Points Question Is the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to primary cytoreductive surgery (PCS) associated with better outcomes for patients with stage III epithelial ovarian cancer?
Z. Lei, Yue Wang, Jiahong Wang, Ke Wang, Jun Tian, Ying Zhao, Lipai Chen, Jin Wang, Jiali Luo, M. Jia, Hong-sheng Tang, Qingjun He, Quanxing Liao, Xiansheng Yang, T. Guan, Li Wang, S. Cui   +16 more
semanticscholar   +1 more source

Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy

International Journal of Molecular Sciences, 2021
Cisplatin is one of the most widely used chemotherapeutic agents in oncology, although its nephrotoxicity limits application and dosage. We present the results of a clinical study on prophylaxis of cisplatin-induced nephrotoxicity in patients with ...
M. Zaballos, M. Power, María Iluminada Canal-Alonso, M. González-Nicolás, Wenceslao Vasquez-Jimenez, P. Lozano-Lominchar, Pilar Cabrerizo-Torrente, Natividad Palencia-García, Susana Gago-Quiroga, M. D. Ginel-Feito, C. Jiménez, A. Lázaro, L. González-Bayón   +12 more
semanticscholar   +1 more source

Analgesia for Thoracic Surgery: Does Intraoperative Methadone Deserve a Place?

ANZ Journal of Surgery, Volume 95, Issue 11, Page 2253-2255, November 2025.
Intraoperative methadone: potential benefits and considerations for thoracic surgery analgesia.
Eugene Constantine Lai, William Thomas Birkett, Luxmana Jeganathan, Ashley St John, Anurag Vijay, Walston Reginald Martis   +5 more
wiley   +1 more source

Hyperthermic intraperitoneal chemotherapy in colorectal cancer

BJS Open
Abstract Background This study evaluated the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer with peritoneal metastases (pmCRC) in a large international data set of patients.
Oliver M Fisher, Chris Brown, Jesus Esquivel, Stein G Larsen, Winston Liauw, Nayef A Alzahrani, David L Morris, Vahan Kepenekian, Isabelle Sourrouille, Frédéric Dumont, Jean-Jacques Tuech, Cécilia Ceribelli, Béranger Doussot, Olivia Sgarbura, Mohammed Alhosni, Francois Quenet, Olivier Glehen, Peter H Cashin, Kjersti Flatmark, Wilhelm Graf, Heikki Takala, Andrew M Lowy, Terence Chua, Joerg Pelz, Dario Baratti, Joel M Baumgartner, Richard Berri, Pedro Bretcha-Boix, Marcello Deraco, Guillermo Flores-Ayala, Alberto Gomez-Portilla, Santiago González-Moreno, Martin Goodman, Evgenia Halkia, Shigeki Kusamura, Mecker Moller, Guillaume Passot, Marc Pocard, George Salti, Armando Sardi, Maheswari Senthil, John Spilioitis, Juan Torres-Melero, Kiran Turaga, Jean-Marc Bereder, Jean-Louis Bernard, Naoual Bakrin, Sébastien Carrère, Julien Coget, Eddy Cotte, Olivier Facy, Maximiliano Gelli, François-Noël Gilly, Pablo Ortega-Deballon, Guillaume Passot, Patrick Rat, Pascal Rousset, Emilie Thibaudeau, Delphine Vaudoyer   +58 more
openaire   +5 more sources

Advances in the Treatment of Colorectal Cancer with Peritoneal Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

The Ewha Medical Journal, 2023
In stage IV colorectal cancer (CRC), peritoneal metastasis is associated with a poor prognosis. Hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery (CRS) is an effective treatment option ...
Youngbae Jeon, Eun Jung Park
doaj   +1 more source

Peritoneal Immunosurgery: Immunotherapy Augmented Surgery for the Treatment of Peritoneal Cancers

Journal of Surgical Oncology, Volume 132, Issue 5, Page 789-809, October 2025.
ABSTRACT Peritoneal malignancy often indicates disruptions in multiple physiological systems resulting from widespread cancer. The heterogenous origin and dynamic nature of peritoneal cancer make it difficult to treat with standard approaches that fit into guidelines.
Ada I. Ozcan, Arianexys Aquino López, Mary K. McKenna, Malcolm K. Brenner, Alastair M. Thompson   +4 more
wiley   +1 more source

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy [PDF]

Indian Journal of Surgical Oncology, 2016
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) combined have been recognized as standard of care for treatment of a subset of patients with peritoneal carcinomatosis (PC). The aim of CRS is to eliminate all macroscopic disease through a series of visceral resections followed by targeting any residual microscopic ...
S. J. Valle, N. A. Alzahrani, W. Liauw, P. H. Sugarbaker, A. Bhatt, D. L. Morris   +5 more
openaire   +2 more sources

Coagulopathy and Venous Thromboembolic Events Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Annals of Surgical Oncology, 2021
Coagulopathy after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is recognized but few details have been studied. The aim of this study was to investigate changes in coagulation biomarkers and their predictive ability ...
P. Dranichnikov, H. Mahteme, P. Cashin, W. Graf   +3 more
semanticscholar   +1 more source

Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer

World Journal of Surgical Oncology, 2019
Background This study aimed to evaluate the clinical outcomes of concurrent liver resection with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer patients with synchronous liver and peritoneal metastases.
Youngbae Jeon, Eun Jung Park, Jin Hong Lim, Seung Hyuk Baik   +3 more
doaj   +1 more source

Closed‐Incision Negative Pressure Therapy: Scoping Review and Multidisciplinary Consensus Recommendations of the Spanish Observatory of Infection in Surgery

International Wound Journal, Volume 22, Issue 10, October 2025.
ABSTRACT Surgical site infections (SSI) and surgical site complications (SSC) significantly impact surgery outcomes, increasing hospital stays and mortality rates, and negatively affecting patients' quality of life. Closed‐incision negative pressure therapy (ciNPT) emerged as a prophylactic strategy to reduce these complications.
Josep M. Badia, Inés Rubio‐Pérez, Carlos Morales‐Pérez, José Bueno‐Lledó, Laura M. Rodríguez‐Lorenzo, Joan Sancho, Oliver Marín‐Peña, Susana López, Jaume Masià, José M. Balibrea   +9 more
wiley   +1 more source